Skip to main content
Shanghai Kindly Enterprise Development Group Co.,Ltd. logo

Shanghai Kindly Enterprise Development Group Co.,Ltd. — Investor Relations & Filings

Ticker · 603987 ISIN · CNE100003076 LEI · 3003003G07QZESUB1P38 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,380 across all filing types
Latest filing 2022-06-29 Board/Management Inform…
Country CN China
Listing Shanghai Stock Exchange 603987

About Shanghai Kindly Enterprise Development Group Co.,Ltd.

https://www.kindly-group.com/

Shanghai Kindly Enterprise Development Group Co., Ltd. specializes in the research, development, and manufacturing of medical puncture instruments and related consumables. The company's product portfolio includes a wide range of hypodermic needles, syringes, infusion sets, and blood collection devices. KDL also produces specialized medical components such as insulin needles, dental needles, and aesthetic medical instruments. With a focus on precision engineering and high-quality standards, the group serves a global market, providing essential medical supplies to healthcare facilities and distributors. The company maintains a comprehensive production chain from raw materials to finished products, ensuring consistency and safety in clinical applications.

Recent filings

Filing Released Lang Actions
上海康德莱企业发展集团股份有限公司第四届董事会第二十一次会议决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 21st meeting of the 4th Board of Directors of Shanghai Kangdelai Enterprise Development Group Co., Ltd. It includes voting results, descriptions of the matters discussed, and references to related reports and legal opinions. The content focuses on board decisions regarding a major asset restructuring and related compliance matters. It is not a full financial report, audit report, or earnings release, but rather a formal disclosure of board meeting resolutions. This fits the category of Board/Management Information (MANG), which covers announcements of changes or decisions by the board of directors or senior management. The document length is about 4400 characters, which is sufficient for a detailed board meeting resolution announcement. Therefore, the classification is MANG with high confidence.
2022-06-29 Chinese
光大证券股份有限公司关于本次重组内幕信息知情人登记制度的制定和执行情况的核查意见
Audit Report / Information Classification · 95% confidence The document is a verification opinion from an independent financial advisor (光大证券股份有限公司) regarding the establishment and execution of an insider information registration system related to a major asset restructuring of 上海康德莱企业发展集团股份有限公司. It references compliance with regulatory rules on major asset restructuring and insider information management. The document is short (1099 characters) and focuses on the internal control and regulatory compliance aspects of the restructuring process, rather than presenting financial data or detailed restructuring terms. It is not a full report on the restructuring itself, nor a merger proxy or tender offer document. It is also not a general regulatory filing or announcement but a specific audit or verification opinion related to the restructuring process. This fits best under Audit Report / Information (AR), which includes standalone audit reports and regulatory compliance verifications related to corporate actions excluding full annual reports or merger filings. FY 2024
2022-06-29 Chinese
德恒上海律师事务所关于上海康德莱企业发展集团股份有限公司重大资产不再纳入合并范围的法律意见
Audit Report / Information Classification · 95% confidence The document is a detailed legal opinion issued by a law firm regarding a significant asset restructuring of Shanghai Kangdelai Enterprise Development Group Co., Ltd. It discusses the removal of a major asset from the consolidated financial statements, the legal basis for the restructuring, the qualifications of the parties involved, approvals obtained and pending, and compliance with relevant laws and regulations. The document references specific laws, regulatory approvals, and detailed corporate and financial information related to the restructuring. It is not a full annual or interim financial report, nor is it a brief announcement or a transcript. It is a standalone legal opinion related to a major asset restructuring, which fits the category of an Audit Report / Information (AR) as it provides legal audit and compliance opinions on a significant corporate restructuring event. The document length (15,000 characters) and content confirm it is a full legal opinion report, not merely an announcement or certification. Therefore, the appropriate classification is AR with high confidence. FY 2021
2022-06-29 Chinese
关于本次重组评估报告不适用的说明
Regulatory Filings
2022-06-29 Chinese
光大证券股份有限公司关于上海康德莱企业发展集团股份有限公司重大资产不再纳入合并范围之独立财务顾问报告
Audit Report / Information Classification · 95% confidence The document is titled as an "Independent Financial Advisor Report" by Everbright Securities Co., Ltd. regarding a significant asset no longer included in the consolidation scope of Shanghai Kangdelai Enterprise Development Group Co., Ltd. The text references compliance with various Chinese securities laws and regulations, including the Company Law, Securities Law, and specific listing rules. It discusses a major asset restructuring that does not involve share issuance or change in control, and it is explicitly stated that this constitutes a "major asset restructuring" but not a "restructuring listing." The document includes detailed financial data, analysis of the impact on the company, and the independent financial advisor's opinions and commitments. This type of report is typical for standalone advisory or audit-related reports concerning major asset restructuring transactions, distinct from full annual or interim reports. It is not a general annual report (10-K), earnings release, or a simple announcement. It is a comprehensive independent financial advisor report related to a major asset restructuring transaction. Therefore, the most appropriate classification is Audit Report / Information (AR). H1 2022
2022-06-29 Chinese
上海康德莱医疗器械股份有限公司关于本次重组相关主体不存在《上市公司监管指引第7号--上市公司重大资产重组相关股票异常交易监管》第十三条情形的说明
Regulatory Filings
2022-06-29 Chinese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.